AR087654A1 - METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO - Google Patents

METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO

Info

Publication number
AR087654A1
AR087654A1 ARP120103114A ARP120103114A AR087654A1 AR 087654 A1 AR087654 A1 AR 087654A1 AR P120103114 A ARP120103114 A AR P120103114A AR P120103114 A ARP120103114 A AR P120103114A AR 087654 A1 AR087654 A1 AR 087654A1
Authority
AR
Argentina
Prior art keywords
pestivirus
bvdv
erns
protein
american
Prior art date
Application number
ARP120103114A
Other languages
English (en)
Spanish (es)
Inventor
G Ankenbauer Robert
D Nelson Lynn
L Oien Nancee
W Welch Siao-Kun
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46970364&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR087654(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of AR087654A1 publication Critical patent/AR087654A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • G01N2333/183Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
ARP120103114A 2011-08-24 2012-08-23 METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO AR087654A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161526792P 2011-08-24 2011-08-24

Publications (1)

Publication Number Publication Date
AR087654A1 true AR087654A1 (es) 2014-04-09

Family

ID=46970364

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103114A AR087654A1 (es) 2011-08-24 2012-08-23 METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO

Country Status (25)

Country Link
US (1) US9291624B2 (enExample)
EP (1) EP2748612B1 (enExample)
JP (1) JP6080850B2 (enExample)
KR (1) KR101667122B1 (enExample)
CN (1) CN103917874B (enExample)
AR (1) AR087654A1 (enExample)
AU (1) AU2012298229B2 (enExample)
BR (1) BR112014004261B8 (enExample)
CA (1) CA2846385C (enExample)
CL (1) CL2014000434A1 (enExample)
CY (1) CY1119873T1 (enExample)
DK (1) DK2748612T3 (enExample)
ES (1) ES2647764T3 (enExample)
HR (1) HRP20171623T1 (enExample)
HU (1) HUE034632T2 (enExample)
LT (1) LT2748612T (enExample)
ME (1) ME02909B (enExample)
MX (1) MX351704B (enExample)
NO (1) NO2746715T3 (enExample)
PL (1) PL2748612T3 (enExample)
PT (1) PT2748612T (enExample)
RS (1) RS56579B1 (enExample)
SI (1) SI2748612T1 (enExample)
UY (1) UY34286A (enExample)
WO (1) WO2013027149A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201113942D0 (en) * 2011-08-12 2011-09-28 Nec Corp Communication system
JP6080850B2 (ja) 2011-08-24 2017-02-15 ゾエティス・サービシーズ・エルエルシー 改善されたワクチン診断法
CN103197082B (zh) * 2013-04-16 2015-07-15 深圳出入境检验检疫局动植物检验检疫技术中心 牛病毒性腹泻病毒抗体快速检测试纸条
HUE038721T2 (hu) * 2013-12-19 2018-11-28 Intervet Int Bv Javított diagnosztikus teszt CSFV antitestek számára
MX2018008085A (es) * 2015-12-30 2018-08-23 Intervet Int Bv Vacuna marcadora contra pestivirus.
CN109136267B (zh) * 2018-09-19 2023-03-31 天康生物股份有限公司 BVDV Erns蛋白和抗体及筛选BVDV感染的牛的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001613A (en) 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
EP0924298A1 (en) * 1997-12-18 1999-06-23 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Protein expression in baculovirus vector expression systems
CA2297694C (en) * 1999-02-12 2008-04-22 Akzo Nobel N.V. Antibodies and diagnostic methods for the diagnosis of pestviruses
EP2365082A1 (en) * 2000-06-27 2011-09-14 Pfizer Animal Health S.A. BVDV virus-like particles
CN1460857A (zh) * 2003-06-10 2003-12-10 陈睿锋 牛病毒性腹泻病毒抗体间接elisa检测方法
US7763460B2 (en) * 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
RU2524426C2 (ru) 2008-12-03 2014-07-27 Пфайзер Инк. ВИРУС ДИАРЕИ КРУПНОГО РОГАТОГО СКОТА С МОДИФИЦИРОВАННЫМ БЕЛКОМ Erns
CN102023217A (zh) * 2010-12-01 2011-04-20 扬州大学 牛病毒性腹泻病毒双抗夹心生物素-亲和素elisa检测试剂盒及使用方法
JP6080850B2 (ja) 2011-08-24 2017-02-15 ゾエティス・サービシーズ・エルエルシー 改善されたワクチン診断法

Also Published As

Publication number Publication date
BR112014004261B1 (pt) 2021-02-02
NO2746715T3 (enExample) 2018-02-03
CY1119873T1 (el) 2018-06-27
HUE034632T2 (en) 2018-02-28
ES2647764T3 (es) 2017-12-26
CA2846385A1 (en) 2013-02-28
DK2748612T3 (da) 2017-11-13
RS56579B1 (sr) 2018-02-28
KR20140064884A (ko) 2014-05-28
US20140302488A1 (en) 2014-10-09
JP2014524583A (ja) 2014-09-22
KR101667122B1 (ko) 2016-10-17
ME02909B (me) 2018-04-20
HRP20171623T1 (hr) 2017-12-01
US9291624B2 (en) 2016-03-22
MX2014002170A (es) 2014-08-01
LT2748612T (lt) 2017-11-27
JP6080850B2 (ja) 2017-02-15
EP2748612A1 (en) 2014-07-02
AU2012298229A1 (en) 2014-03-06
SI2748612T1 (sl) 2017-12-29
UY34286A (es) 2013-04-05
EP2748612B1 (en) 2017-09-20
MX351704B (es) 2017-10-24
CN103917874A (zh) 2014-07-09
NZ621257A (en) 2015-04-24
PL2748612T3 (pl) 2018-01-31
BR112014004261A2 (pt) 2017-03-21
WO2013027149A1 (en) 2013-02-28
PT2748612T (pt) 2017-11-21
CL2014000434A1 (es) 2014-12-05
AU2012298229A9 (en) 2015-12-10
HK1194814A1 (zh) 2014-10-24
BR112014004261B8 (pt) 2022-11-08
AU2012298229B2 (en) 2015-12-10
CA2846385C (en) 2017-12-19
CN103917874B (zh) 2016-02-03

Similar Documents

Publication Publication Date Title
AR078423A1 (es) Vacunas dirigidas a las celulas de langerhans
MX2015012825A (es) Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
AR087654A1 (es) METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
MX2019008221A (es) Anticuerpo anti-gpc3.
AR095432A1 (es) Proteínas de unión a antígeno
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
MX2018008421A (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
MX2023000738A (es) Proteinas de union a antigeno que activan el receptor de leptina.
GT200800269A (es) Una novedosa virulencia determinada dentro de la glicoproteina estructural e2 del virus clasico de la fiebre porcina
PE20170916A1 (es) Composiciones y metodos para anticuerpos dirigidos a bmp6
BR112016014010A2 (pt) métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador
MX2021008268A (es) Tratamiento de cefalea por uso excesivo de medicamentos usando anticuerpos anti-cgrp o anti-cgrp-r.
MX2015000686A (es) Metodo para detectar cancer.
BR112016016737A2 (pt) Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma
CL2021002727A1 (es) Vacuna con subunidades del vfpc
NZ631110A (en) Marker vaccine
PE20220004A1 (es) Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh
MX383206B (es) Preparación de anticuerpos de cultivos de célula de ovario de hámster chino para conjugación.
AR105379A1 (es) Dispositivo para detectar proteínas mal plegadas y sus métodos de uso
MX2016013277A (es) Vacuna para estreptococo de grupo a.
AR107440A1 (es) ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO pIII DE ADENOVIRUS HUMANO (ADV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR ADV
CO2021008774A2 (es) Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu

Legal Events

Date Code Title Description
FG Grant, registration